Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$233.45 - $247.73 $131,432 - $139,471
-563 Reduced 20.97%
2,122 $525,000
Q4 2023

Jan 24, 2024

SELL
$232.24 - $267.23 $34,371 - $39,550
-148 Reduced 5.22%
2,685 $654,000
Q3 2023

Oct 30, 2023

SELL
$254.9 - $283.59 $31,862 - $35,448
-125 Reduced 4.23%
2,833 $732,000
Q2 2023

Jul 21, 2023

SELL
$238.39 - $265.32 $54,352 - $60,492
-228 Reduced 7.16%
2,958 $780,000
Q1 2023

Apr 27, 2023

SELL
$229.71 - $259.35 $16,079 - $18,154
-70 Reduced 2.15%
3,186 $788,000
Q4 2022

Feb 07, 2023

SELL
$218.29 - $256.91 $41,475 - $48,812
-190 Reduced 5.51%
3,256 $828,000
Q3 2022

Oct 20, 2022

SELL
$51.03 - $264.23 $116,348 - $602,444
-2,280 Reduced 39.82%
3,446 $768,000
Q2 2022

Jul 20, 2022

SELL
$234.74 - $275.42 $237,322 - $278,449
-1,011 Reduced 15.01%
5,726 $1.41 Million
Q1 2022

Apr 21, 2022

SELL
$243.64 - $270.48 $75,528 - $83,848
-310 Reduced 4.4%
6,737 $1.79 Million
Q4 2021

Jan 20, 2022

SELL
$230.08 - $250.94 $324,642 - $354,076
-1,411 Reduced 16.68%
7,047 $1.77 Million
Q3 2021

Oct 13, 2021

SELL
$232.72 - $256.47 $11,636 - $12,823
-50 Reduced 0.59%
8,458 $2.08 Million
Q2 2021

Aug 02, 2021

SELL
$232.65 - $254.58 $12,795 - $14,001
-55 Reduced 0.64%
8,508 $2.07 Million
Q1 2021

Apr 20, 2021

SELL
$232.09 - $256.88 $1,856 - $2,055
-8 Reduced 0.09%
8,563 $2.08 Million
Q4 2020

Feb 02, 2021

SELL
$221.92 - $245.94 $65,466 - $72,552
-295 Reduced 3.33%
8,571 $2.15 Million
Q3 2020

Nov 04, 2020

BUY
$215.77 - $276.76 $353,647 - $453,609
1,639 Added 22.68%
8,866 $2.06 Million
Q2 2020

Jul 15, 2020

BUY
$219.9 - $263.41 $1.59 Million - $1.9 Million
7,227 New
7,227 $1.73 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Capital Insight Partners, LLC Portfolio

Follow Capital Insight Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Insight Partners, LLC with notifications on news.